BioCentury
ARTICLE | Clinical News

Lotemax: Phase IV trial

January 2, 1996 8:00 AM UTC

Pharmos Corp. (PARS), Alachua, Fla. Bausch & Lomb Pharmaceuticals, Rochester, N.Y. Product: Lotemax (loteprednol etabonate) topical steroid anti-inflammatory Indication: Uveitis, a severe inflamma...